Clinical Trials Sponsored by BioSante Pharmaceuticals

Total 19662 results

BioSante Pharmaceuticals

Completed

Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women (BLOOM)

Hypoactive Sexual Desire Disorder

United States, Canada
BioSante Pharmaceuticals

Completed

Efficacy and Safety of a Topical Estradiol Gel for Treatment of Postmenopausal Symptoms

Hot Flashes
BioSante Pharmaceuticals

Completed

Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)

Hypoactive Sexual Desire Disorder

United States, Canada
BioSante Pharmaceuticals

Completed

Safety and Efficacy of LibiGel® for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women (BLOOM)

Hypoactive Sexual Desire Disorder

United States, Canada
BioSante Pharmaceuticals

Completed

Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women (BLOOM)

Hypoactive Sexual Desire Disorder

United States, Canada
Biosite

Completed

BRAIN (Biomarker Rapid Assessment of Ischemic iNjury)

Stroke | Stroke Mimic(Conditions Presenting With Stroke-like Conditions)

United States, Canada, Germany, Switzerland, United Kingdom
Biosite

Withdrawn

Multi-marker INDex for the Risk Assessment of Sepsis in the Emergency departmenT (MINDSET) (MINDSET)

Sepsis

United States
Biosite

Terminated

Rapid Assessment of Bedside BNP In Treatment of Heart Failure (RABBIT)

Heart Failure

United States
Biosite

Completed

Evaluation of the Accuracy of the INRatio Prothrombin Time (PT) Monitoring System With a New Test Strip for the Oral Anticoagulation Therapy Patient in the Presence of Heparin and Low Molecular Weight Heparin (e.g., Enoxaparin or Dalteparin) (ECLIPSE 03)

Coagulation

United States
Biosite

Completed

Neutrophil Gelatinase-Associated Lipcalin (NGAL) Evaluation Along With B-Type Natriuretic Peptide in Acutely Decompensated HF (GALLANT)

Acute Decompensated Heart Failure

United States, Netherlands, Switzerland
Biosite

Completed

Myeloperoxidase and Multi-Markers In the Diagnosis of Diagnoses of Acute Coronary Syndrome (MIDAS) - Sample Procurement

Acute Coronary Syndrome (ACS)

United States
Biosite

Completed

Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU (REAL-ICU)

Acute Kidney Injury

United States, Canada
Biosite

Completed

SHORTness of Breath In the Emergency Department (SHORTIE)

Heart Failure | Pulmonary Embolism | Acute Myocardial Infarction

United States
Biosite

Withdrawn

Evaluation of Serial Troponin and Cardiac Multimarkers at the Point of Care in the Emergency Department (ESTIMATE)

Chest Pain | Acute Coronary Syndrome | Acute Myocardial Infarction

United States
Biosite

Completed

Evaluation of the Accuracy and Precision of the INRatio® Prothrombin Time (PT) Monitoring System With New INRatio Test Strip Designed for Low Sample Volume and Heparin Insensitivity (ECLIPSE-01)

Atrial Fibrillation | Deep Vein Thrombosis | Pulmonary Embolism

United States
Biosite

Completed

Triage Now: an Observational, Prospective Multimarker Study of Biomarkers in Patients Presenting With Chest Pain

Myocardial Infarction | Acute Coronary Syndrome

Germany
Biosense Webster EMEA

Terminated

CACAF2 Study: Catheter Ablation for Cure of Atrial Fibrillation (CACAF-2)

Atrial Fibrillation

Italy, United Kingdom, Finland
Biosite

Completed

Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT II)

Heart Failure

United States
Biosite

Withdrawn

Clinical Performance Evaluation of the Cholestech LDX Cardiac hsCRP Test (CLEAR) (CLEAR)

Cardiovascular Disease

United States
Biosite

Withdrawn

Rapid Assessment of Cardiac Markers for the Evaluation of Acute Coronary Syndrome (RACE-ACS)

Acute Coronary Syndrome

United States
Biosite

Completed

User Performance Evaluation of the INRatio® Prothrombin Time (PT) Monitoring System With a New INRatio Test Strip Designed for Low Sample Volume and Heparin Insensitivity (ECLIPSE-02)

Oral Anticoagulation

United States
Biosite

Completed

Multi-Markers In the Diagnosis of Acute Coronary Syndrome (Midas 3)

Acute Coronary Syndrome

United States
Biosite

Completed

Neutrophil Gelatinase-associated Lipocalin (NGAL) Evaluation in Emergency Department (ED) All-Comers

Acute Kidney Injury

Italy
Biosite

Completed

Neutrophil Gelatinase-associated Lipcalin(NGAL): A Novel Blood Marker for Determining the Risk of Developing Contrast-Induced Nephopathy (ENCINO)

Cardiovascular Surgery With Coronary Angiography

United States
Biosite

Completed

Evaluation of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Early and Evolving Acute Kidney Injury (EVOLVE)

Kidney Failure, Acute

United States, Canada
Biosense Webster EMEA

Completed

FLAT Study: First Line Ablation Therapy for Treatment of Paroxysmal Atrial Fibrillation (RAAFT)

Atrial Fibrillation

Italy
Biosense Webster EMEA

Completed

European Carto® XP REgistry for Validating Specialized CFAE SOftware (EXPRESSO)

Atrial Fibrillation

France, Germany, Hungary
Biosense Webster, Inc.

Recruiting

A Study of the THERMOCOOL SMARTTOUCH Surround Flow (SF) Catheter With the TRUPULSE Generator for Treatment of Drug Refractory Symptomatic PAFOUS (PulseSmart)

Atrial Fibrillation

Australia, Canada
Biosense Webster, Inc.

Recruiting

A Study For Treatment of Paroxysmal Atrial Fibrillation (PAF) With the OMNYPULSE Catheter and the TRUPULSE Generator (Omny-IRE)

Atrial Fibrillation

Belgium, Canada, Netherlands, Lithuania, Croatia, Germany, Italy, Czechia
Biosense Webster, Inc.

Active, not recruiting

A Study of Multi-electrode Circular Irreversible Electroporation (IRE) Catheter and Multi-Channel IRE Generator in Paroxysmal Atrial Fibrillation (AF) (AFIRE)

Refractory Paroxysmal Atrial Fibrillation

China
Biosense Webster, Inc.

Completed

Evaluation of QDOT MICRO™ Catheter for Pulmonary Vein Isolation in Subjects With Paroxysmal Atrial Fibrillation (Q-FFICIENCY)

Paroxysmal Atrial Fibrillation

United States
Biosense Webster, Inc.

Completed

Multi-electrode Radiofrequency Balloon Catheter Use for the Isolation of the Pulmonary Veins. (SHINE)

Paroxysmal Atrial Fibrillation

United Kingdom, Italy, Czechia
Biosense Webster, Inc.

Terminated

Atrial Fibrillation Progression Trial (ATTEST)

Atrial Fibrillation

Korea, Republic of, Germany, Belgium, Norway, Austria, Ireland, United Kingdom, Australia, Spain, Sweden, Latvia, Hungary, Italy, Poland, Russian Federation
Biosense Webster, Inc.

Completed

Repetitive Activation Patterns and Focal Impulses Identification and Ablation in Persistent AF (RAPID-AF)

Persistent Atrial Fibrillation

United Kingdom, Belgium, Czechia, Canada
Biosense Webster, Inc.

Completed

Evaluation of a Multi-electrode Linear Type Catheter (D-1368-01-SI)

Persistent Atrial Fibrillation

United Kingdom, Italy
Biosense Webster, Inc.

Terminated

nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation

Atrial Fibrillation

United States, United Kingdom, Italy, Czechia, Belgium, Hungary
Biosense Webster, Inc.

Completed

SMART China, A Multi-center Clinical Registry Study

Atrial Fibrillation

China
Biosense Webster, Inc.

Completed

THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation CONTINUED ACCESS

Drug Refractory Symptomatic Paroxysmal Atrial Fibrillation

United States
Biosense Webster, Inc.

Completed

FIND CAN Trial: "CF-172" (FIND CAN)

Persistent Atrial Fibrillation

Canada
Biosense Webster, Inc.

Terminated

Guided Radiofrequency Ablation Using the CARTO® 3 and NavX™ Systems for the Treatment of Paroxysmal Atrial Fibrillation (CO1)

Paroxysmal Atrial Fibrillation

Canada
Biosense Webster, Inc.

Withdrawn

CARTO 3 Human Patch Study (Human Patch)

Healthy
Biosense Webster, Inc.

Completed

Study of a New Catheter Using Force Sensing Capabilities for the Treatment of Atrial Fibrillation and Ventricular Tachycardia (EZCF-125)

Atrial Fibrillation | Ischemic Ventricular Tachycardia

Czech Republic
Biosense Webster, Inc.

Terminated

Efficacy, Safety and Efficiency Study of CARTO® 3 System Guided THERMOCOOL® Catheter Ablation Versus Fluoroscopy Guided Ablation With the Pulmonary Vein Ablation Catheter® (PVAC®) (CLARITY-AF)

Atrial Fibrillation

Netherlands, Belgium, Canada, Denmark, Germany, United Kingdom
Biosense Webster, Inc.

Completed

THERMOCOOL® SMARTTOUCH™ Registry

Symptomatic Atrial Fibrillation

Belgium, Germany, United Kingdom, Canada, Australia, France, Italy, Monaco
Biosense Webster, Inc.

Completed

Assessment of Safety and Effectiveness in Treatment Management of Atrial Fibrillation With the BWI IRE Ablation System (AdmIRE)

Atrial Fibrillation

United States
Biosense Webster, Inc.

Completed

A Study of Intracardiac Ultrasound With the NUVISION NAV Ultrasound Catheter

Ventricular Tachycardia | Paroxysmal Atrial Fibrillation | Persistent Atrial Fibrillation | Scar-related Atrial Tachycardia | Premature Ventricular Complex

Croatia, Italy, Israel
Biosense Webster, Inc.

Completed

A Study Assessing Arrhythmia Mapping With a Globe-Shaped, High-Density, Multi-Electrode Mapping Catheter (COSMOS)

Ventricular Tachycardia | Paroxysmal Atrial Fibrillation | Persistent Atrial Fibrillation | Scar-related Atrial Tachycardia | Premature Ventricular Complex

Croatia, Belgium, Italy
Biosense Webster, Inc.

Completed

Evaluation of VISITAG SURPOINT™ Module With External Processing Unit (EPU)

Paroxysmal Atrial Fibrillation

United States
Biosense Webster, Inc.

Completed

A Study for Treatment of Paroxysmal Atrial Fibrillation (PAF) by Pulsed Field Ablation (PFA) System With Irreversible Electroporation (IRE) (inspIRE)

Atrial Fibrillation

Canada, Belgium, Austria, Croatia, Czechia, France, Italy, Lithuania
Biosense Webster, Inc.

Completed

Performance of QDOT Micro™ Catheter With nGEN Generator for Patients With AFIB.

Atrial Fibrillation

Canada

3

Subscribe